pirenzepine has been researched along with Neuronal Ceroid-Lipofuscinoses in 1 studies
Pirenzepine: An antimuscarinic agent that inhibits gastric secretion at lower doses than are required to affect gastrointestinal motility, salivary, central nervous system, cardiovascular, ocular, and urinary function. It promotes the healing of duodenal ulcers and due to its cytoprotective action is beneficial in the prevention of duodenal ulcer recurrence. It also potentiates the effect of other antiulcer agents such as CIMETIDINE and RANITIDINE. It is generally well tolerated by patients.
Neuronal Ceroid-Lipofuscinoses: A group of severe neurodegenerative diseases characterized by intracellular accumulation of autofluorescent wax-like lipid materials (CEROID; LIPOFUSCIN) in neurons. There are several subtypes based on mutations of the various genes, time of disease onset, and severity of the neurological defects such as progressive DEMENTIA; SEIZURES; and visual failure.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Patients with juvenile neuronal ceroid lipofuscinosis (JNCL) often have severe psychiatric symptoms." | 2.70 | New antidepressive and antipsychotic drugs in juvenile neuronal ceroid lipofuscinoses--a pilot study. ( Aberg, LE; Aronen, ET; Bäckman, ML; Santavuori, PR, 2001) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bäckman, ML | 1 |
| Aberg, LE | 1 |
| Aronen, ET | 1 |
| Santavuori, PR | 1 |
1 trial available for pirenzepine and Neuronal Ceroid-Lipofuscinoses
| Article | Year |
|---|---|
New antidepressive and antipsychotic drugs in juvenile neuronal ceroid lipofuscinoses--a pilot study.
Topics: Adolescent; Adult; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Benzodiazepines; | 2001 |